The publication of two papers demonstrates how work led by laboratories from the Department of Cancer and Genomic Sciences, ...

The University of Birmingham and Manufacturing Technology Centre (MTC) led the successful bid, supported by the West Midlands Growth Company and ICC Birmingham.

The new time-saving test is intended for people with MGUS (Monoclonal Gammopathy of Unknown Significance), a precursor condition of myeloma.